Literature DB >> 3319305

Circulating lymphocyte populations and autoantibodies in non-obese diabetic (NOD) mice: a longitudinal study.

O Pontesilli1, P Carotenuto, L S Gazda, P F Pratt, S J Prowse.   

Abstract

Several previous observations indicate a role for the immune system in the pathogenesis of insulin-dependent diabetes mellitus (IDDM) in non-obese diabetic (NOD) mice. In order to assess the status of the immune system in this model of spontaneous diabetes we studied the phenotype of circulating lymphocytes and the humoral autoimmunity to islet cells in non-diabetic NOD mice at various ages. Lymphocyte numbers were low in young NOD mice (age less than 160 days) as compared with other strains of mice and increased later to reach values in or above the range of controls. The percentages of circulating T lymphocytes and their L3T4+ and Lyt2+ subsets were higher in NOD mice of all ages and both sexes than in controls; however, no imbalance of the L3T4+ and Lyt2+ subpopulations was found. Anti-insulin autoantibodies were detected by an ELISA assay in all the NOD mice studied throughout the entire period of observation. Autoantibodies reacting with the cytoplasm of islet cells in Bouin's fixed pancreas sections, likely to be anti-insulin antibodies, were found in 47 to 58% of the samples from NOD mice aged 75 to 150 days. Antibodies to surface antigens of rat insulinoma cells were virtually absent in young NOD mice (75-100 days) and appeared in 33 to 43% of the samples from 150 to 185 days old NOD mice. The autoantibodies and the quantitative lymphocyte abnormalities reported here, although not predictive of the appearance of overt diabetes, are likely to be involved in the pathogenesis of the disease and therefore may indicate directions for future investigations.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3319305      PMCID: PMC1542201     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  A receptor for Fc on mouse B-lymphocytes.

Authors:  F Paraskevas; S T Lee; K B Orr; L G Israels
Journal:  J Immunol       Date:  1972-05       Impact factor: 5.422

2.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

Authors:  G F Bottazzo; A Florin-Christensen; D Doniach
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

3.  IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement.

Authors:  M Sarmiento; A L Glasebrook; F W Fitch
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

4.  Autoantibodies to islet cells: comparison of methods.

Authors:  S Yagihashi; H Suzuki; M J Dobersen; T Onodera; A L Notkins; F Ginsberg-Fellner
Journal:  Lancet       Date:  1982-11-27       Impact factor: 79.321

5.  Effects of cytotoxic monoclonal antibody specific for T200 glycoprotein on functional lymphoid cell populations.

Authors:  G Dennert; R Hyman; J Lesley; I S Trowbridge
Journal:  Cell Immunol       Date:  1980-08-01       Impact factor: 4.868

6.  Islet-cell-surface antibodies in juvenile diabetes mellitus.

Authors:  A Lernmark; Z R Freedman; C Hofmann; A H Rubenstein; D F Steiner; R L Jackson; R J Winter; H S Traisman
Journal:  N Engl J Med       Date:  1978-08-24       Impact factor: 91.245

7.  Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus.

Authors:  M J Dobersen; J E Scharff; F Ginsberg-Fellner; A L Notkins
Journal:  N Engl J Med       Date:  1980-12-25       Impact factor: 91.245

8.  In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis.

Authors:  G F Bottazzo; B M Dean; J M McNally; E H MacKay; P G Swift; D R Gamble
Journal:  N Engl J Med       Date:  1985-08-08       Impact factor: 91.245

9.  Continuous, clonal, insulin- and somatostatin-secreting cell lines established from a transplantable rat islet cell tumor.

Authors:  A F Gazdar; W L Chick; H K Oie; H L Sims; D L King; G C Weir; V Lauris
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

10.  Breeding of a non-obese, diabetic strain of mice.

Authors:  S Makino; K Kunimoto; Y Muraoka; Y Mizushima; K Katagiri; Y Tochino
Journal:  Jikken Dobutsu       Date:  1980-01
View more
  17 in total

Review 1.  The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.

Authors:  C Boitard
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

2.  Insulin autoantibodies in non-obese diabetic (NOD) mice.

Authors:  C Michel; C Boitard; J F Bach
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

3.  An update on the use of NOD mice to study autoimmune (Type 1) diabetes.

Authors:  Rodolfo José Chaparro; Teresa P Dilorenzo
Journal:  Expert Rev Clin Immunol       Date:  2010-11       Impact factor: 4.473

4.  Peripherin: an islet antigen that is cross-reactive with nonobese diabetic mouse class II gene products.

Authors:  C Boitard; M C Villa; C Becourt; H P Gia; C Huc; P Sempe; M M Portier; J F Bach
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

5.  Natural thymocytotoxic autoantibodies in non-obese diabetic (NOD) mice: characterization and fine specificity.

Authors:  A Lehuen; J Altman; J F Bach; C Carnaud
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

6.  Longitudinal study of islet cell antibodies and insulin autoantibodies and development of diabetes in non-obese diabetic (NOD) mice.

Authors:  S Reddy; N Bibby; R B Elliott
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

7.  Cell-mediated immunity to pancreatic islet cells in the non-obese diabetic (NOD) mouse: in vitro characterization and time course study.

Authors:  J Timsit; M Debray-Sachs; C Boitard; J F Bach
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

8.  The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice.

Authors:  A Signore; P Pozzilli; E A Gale; D Andreani; P C Beverley
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

9.  Histological study of pancreatic beta-cell loss in relation to the insulitis process in the non-obese diabetic mouse.

Authors:  A Signore; E Procaccini; A M Toscano; E Ferretti; A J Williams; P E Beales; P Cugini; P Pozzilli
Journal:  Histochemistry       Date:  1994-04

10.  Autoimmune diabetes-prone NOD mice express the Lyt2 alpha (Lyt2.1) and Lyt3 alpha (Lyt3.1) alleles of CD8.

Authors:  J M Johnson-Tardieu; E W Walworth; J G Cornelius; X Ye; S M Schuster; A B Peck
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.